Prevalence of hepatitis A antibodies in Swiss travellers.
To assess the prevalence of antibodies to hepatitis A virus (anti-HAV) in future travellers, all visitors to the Zurich University Vaccination Center in July/August 1990 were invited to participate in a cross-sectional study.
A total of 1126 future travellers were recruited to have a blood sample drawn and to complete a brief questionnaire.
Among these, 35 refused or were excluded, thus 1091 were evaluated.
The overall prevalence of anti-HAV was 16.5%. This rate was 5.9% in future travellers born in or after 1961, 11.8% in those born 1951-60, 21.4% in those born 1941-50 and exceeded 49% in all decades born in or before 1940.
Mots-clés Pascal : Hépatite virale A, Virose, Infection, Epidémiologie, Prévalence, Sérologie, Voyage, Homme, Suisse, Europe, Foie pathologie, Appareil digestif pathologie
Mots-clés Pascal anglais : Viral hepatitis A, Viral disease, Infection, Epidemiology, Prevalence, Serology, Travel, Human, Switzerland, Europe, Hepatic disease, Digestive diseases
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 93-0412250
Code Inist : 002B05C02G. Création : 199406.